Omnix Medical Advances OMN6 Into Phase II Trial for Drug-Resistant Acinetobacter Infections
As reported on PharmaBiz, Omnix Medical has reached a key clinical milestone with the initiation of patient dosing in a phase II study of its lead antimicrobial candidate, OMN6. The…